Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

405 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Reduction in potentially inappropriate end-of-life hospital care for cancer patients during the COVID-19 pandemic: A retrospective population-based study.
Slotman E, Fransen HP, van Laarhoven HW, van den Beuken-van Everdingen MH, Tjan-Heijnen VC, Huijben AM, Jager A, van Zuylen L, Kuip EJ, van der Linden YM, Raijmakers NJ, Siesling S. Slotman E, et al. Among authors: siesling s. Palliat Med. 2024 Jan;38(1):140-149. doi: 10.1177/02692163231217373. Epub 2023 Dec 23. Palliat Med. 2024. PMID: 38142283 Free PMC article.
The effectiveness of personalised surveillance and aftercare in breast cancer follow-up: a systematic review.
van Maaren MC, van Hoeve JC, Korevaar JC, van Hezewijk M, Siemerink EJM, Zeillemaker AM, Klaassen-Dekker A, van Uden DJP, Volders JH, Drossaert CHC, Siesling S; NABOR project group. van Maaren MC, et al. Among authors: siesling s. Support Care Cancer. 2024 May 2;32(5):323. doi: 10.1007/s00520-024-08530-2. Support Care Cancer. 2024. PMID: 38695938 Free PMC article.
Comparison between de novo and metachronous metastatic breast cancer: the presence of a primary tumour is not the only difference-a Dutch population-based study from 2008 to 2018.
de Maar JS, Luyendijk M, Suelmann BBM, van der Kruijssen DEW, Elias SG, Siesling S, van der Wall E. de Maar JS, et al. Among authors: siesling s. Breast Cancer Res Treat. 2023 Apr;198(2):253-264. doi: 10.1007/s10549-022-06837-4. Epub 2023 Jan 17. Breast Cancer Res Treat. 2023. PMID: 36648694
Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE--5-a population-based study.
De Angelis R, Sant M, Coleman MP, Francisci S, Baili P, Pierannunzio D, Trama A, Visser O, Brenner H, Ardanaz E, Bielska-Lasota M, Engholm G, Nennecke A, Siesling S, Berrino F, Capocaccia R; EUROCARE-5 Working Group. De Angelis R, et al. Among authors: siesling s. Lancet Oncol. 2014 Jan;15(1):23-34. doi: 10.1016/S1470-2045(13)70546-1. Epub 2013 Dec 5. Lancet Oncol. 2014. PMID: 24314615
Cancer risks for other sites in addition to breast in CHEK2 c.1100delC families.
Schreurs MAC, Schmidt MK, Hollestelle A, Schaapveld M; Hereditary Breast and Ovarian Cancer Research Group Netherlands; van Asperen CJ, Ausems MGEM, van de Beek I, Broekema MF, Collée JM, van der Hout AH, van Kaam KJAF, Komdeur FL, Mensenkamp AR, Adank MA, Hooning M. Schreurs MAC, et al. Genet Med. 2024 May 31:101171. doi: 10.1016/j.gim.2024.101171. Online ahead of print. Genet Med. 2024. PMID: 38828701
High-value breast cancer care within resource limitations.
Verhoeven D, Siesling S, Allemani C, Roy PG, Travado L, Bhoo-Pathy N, Rhayns C, Junkermann H, Nakamura S, Lasebikan N, Tucker FL. Verhoeven D, et al. Among authors: siesling s. Oncologist. 2024 May 23:oyae080. doi: 10.1093/oncolo/oyae080. Online ahead of print. Oncologist. 2024. PMID: 38780115 Free article.
405 results